Mevalonate (lithium salt), CAS 2618458-93-6

Mevalonate (lithium salt), CAS 2618458-93-6
Artikelnummer
CAY37476-1
Verpackungseinheit
1 mg
Hersteller
Cayman Chemical

Verfügbarkeit: wird geladen...
Preis wird geladen...
Formulation: A solid

Formal Name: 3,5-dihydroxy-3-methyl-pentanoic acid, lithium salt

Purity: ≥95%

Formula Markup: C6H12O4 • XLi

Formula Weight: 148,2

Shelf life (days): 1460

CAS Number: 2618458-93-6

Notes: Mevalonate is an intermediate in the mevalonate pathway of cholesterol synthesis.{65516} It inhibits cell death induced by the HMG-CoA reductase inhibitor simvastatin (Item Nos. 10010344 / 10010345) in C2C12 myoblasts when used at concentrations ranging from 80 to 110 µM.{65515} Mevalonate (500 µM) reverses decreases in proliferation induced by the HMG-CoA reductase inhibitor lovastatin (Item No. 10010338) in several colon cancer cell lines, including RKO and SW480 cells.{65514} It increases lovastatin-induced decreases in the expression of the genes encoding Axin2, ectodermal-neural cortex 1 (ENC1), BCL2-like 1 (BCL2-L1), and cyclin D1 when used at a concentration of 500 µM. Mevalonate (50 µM) increases Rac1 protein levels, as well as increases Rac1 farnesylation induced by the arachidonic metabolite 15(S)-HETE (Item No. 34720) in human dermal microvascular endothelial cells (HDMVECs).{55558}
Mehr Informationen
Artikelnummer CAY37476-1
Hersteller Cayman Chemical
Hersteller Artikelnummer 37476-1
Green Labware Nein
Verpackungseinheit 1 mg
Mengeneinheit STK
Methode Reinstoffe
Produktinformation (PDF) Download
MSDS (PDF) Download